Another SPAC Merger Goes South

RA Capital, Citadel, Farallon, Suvretta and Perceptive are under water on the recently closed merger between a biopharma company and RA Capital’s SPAC.

Stephen Taub July 22, 2021

(Amir Hamja/Bloomberg)

Another SPAC merger with heavy hedge fund support has turned into a disaster.On June 30, Therapeutics Acquisition Corp. (doing business as Research Alliance Corp. I), a special-purpose acquisition company sponsored by RA Capital Management, completed its merger with POINT Biopharma Inc., which is building a

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Market Intelligence

Data & Analysis

Guest Contributors

II Networks

Insights

Research

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.01 build:2025-12-11 Login